RBM39 and cancer: It is interesting that a proline-to-serine substitution at this same position in human RBM39 changes its conformation and renders resistance to the anti-cancer drug indisulam, an aryl sulfonamide that facilitates RBM39 proteasomal degradation19, highlighting the pivotal role of this residue in regulating RBM39 function.